** Macquarie downgrades Australia's Ansell ANN.AX to "Neutral" rating from "Outperform", trims price target to A$31.05 from A$40.30
** The new price target represents 5.6% premium to stock's close on Tuesday
** U.S. tariffs announced on April 4 present downside for ANN, despite the company expecting to fully offset tariff impacts through pricing - Macquarie
** ANN, known for its medical gloves and surgical gowns, has ~93% of its supply chain facing U.S. reciprocal tariffs greater than 10%, Macquarie says
** Two of 10 analysts rate the stock "buy" and eight "hold"; their median PT is A$38.10 – LSEG data
** Stock down 13.1% YTD
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.